Nutrition therapy for dyslipidemia

Current Diabetes Reports

Volumn 3, Issue 5, 2003, Pages 397-403

  Carson, Jo Ann S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBOHYDRATE; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSANOID; ICOSAPENTAENOIC ACID; ISOFLAVONE; LINOLEIC ACID; LINSEED OIL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MARGARINE; MINERAL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PHYTOSTEROL; SATURATED FATTY ACID; SOYBEAN PROTEIN; STANOL ESTER; TRIACYLGLYCEROL; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN; VITAMIN;

CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CEREAL; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; DIETARY FIBER; DYSLIPIDEMIA; FAT INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; INTERMETHOD COMPARISON; LIPID BLOOD LEVEL; LOW FAT DIET; MACRONUTRIENT; NUTRITIONAL HEALTH; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; REVIEW; SOYBEAN; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL; VEGETABLE; WEIGHT REDUCTION; BLOOD; CHOLESTEROL INTAKE; FEMALE; HYPERLIPIDEMIA; MALE; METABOLIC SYNDROME X; OBESITY;

CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FATS; DIETARY FIBER; ENERGY INTAKE; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; METABOLIC SYNDROME X; OBESITY; PHYTOSTEROLS; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 0242271876     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-003-0084-z     Document Type: Review

References (50)

1. Haffner SM, Lehto S, Ronnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-324.
2. Pyörälä K, Pedersen TR, Kjekshus J, et al.: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandivanvian Simvastatin Survival Study (4S). Diabetes Care 1997, 20:614-620.
3. Sacks FM, Pfeffer MA, Moye LA, et al.: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996, 335:1001-1009.
4. Semenkovich CF: Diabetic dyslipidemia: pathophysiology and treatment. In Ellenberg and Rifkin's Diabetes Mellitus, edn 6. Edited by Porte D, et al. New York: McGraw-Hill; 2002:805-813.
5. National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD: National Institutes of Health; 2001. NIH Publication 01-3670. http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm. Accessed April 1, 2003.
6. Evidence-based nutrition principles and recommendations for the trearment and prevention of diabetes and related complications. American Diabetes Association [no authors listed]. Diabetes Care 2003, 26(suppl 1):S51-S61.
7. Grundy SM: Nutrition and diet in the management of hyperlipidemia and atherosclerosis. In Modern Nutrition in Health and Disease, edn 9. Edited by Shils ME, et al. Baltimore, MD: Lippincott, Williams & Wilkins; 1999:1199-1216.
8. Yu-Poth S, Zhao G, Etherton T, et al.: Effects of the National Cholesterol Education Program's step I and II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999, 69:632-646.
9. Lovejoy JC, Smith SR, Champagne CM, et al.: Effects of diet enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002, 25:1283-1288.
10. Beauchesne-Rondeau E, Gascon A, Bererson J, Jacques H: Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish or poultry. Am J Clin Nutr 2003, 77:587-593.
11. Lichenstein AH, Ausman LM, Jalbert Sm, Schaefer EJ: Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999, 340:1933-1940.
12. Denke MA, Adams-Huet B, Nguyen AT: Individual cholesterol variation in response to a margarine- or butter-based diet: a study in families. JAMA 2000, 284:2740-2747.
13. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims; reopening of the comment period. Food and Drug Administration [no authors listed]. Fed Reg 2002, 67:69171-69172.
14. Krauss RM, Eckel RH, Howard B, et al.: AHA dietary guidelines. Revision 2000: a statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation 2000, 102:2284-2299.
15. Heilbronn LK, Noakes M, Clifton PM: Effect of energy restriction, weight loss and diet composition of plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care 1999, 22:889-895.
16. Ostlund RE: Phytosterols in human nutrition. Annu Rev Nutr 2002, 22:533-549.
17. Temme EH, Van Hoydonck PC, Schouten EG, Kesteloot H: Effects of a plant sterol-enriched spread on serum lipids and lipoproteins in mildly hypercholesterolaemic subjects. Acta Cardiol 2002, 57:111-115.
18. Plat J, van Onselen ENM, van Heugten MMA, Mensink RP: Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nut 2000, 54:671-677.
19. Vanstone CA, Raeini-Sarjaz M, Parsons WE, Jones PJH: Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr 2002, 76:1272-1278.
20. Maki KC, Davidson MH, Umporowicz DM, et al.: Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr 2001, 74:33-43.
21. Chandalia M, Garg A, Lutjohann D, et al.: Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000, 342:1392-1398.
22. Davy BM, Davy KP, Ho RC, et al.: High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men. Am J Clin Nutr 2002, 76:351-358.
23. Anderson JW, Allgood LD, Turner J, et al.: Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr 1999, 70:466-473.
24. Sprecher DL, Pearce GL: Fiber-multivitamin combination therapy: a beneficial influence on low-density lipoprotein and homocysteine. Metabolism 2002, 51:1166-1170.
25. Erdman JW: Soy protein and cardiovascular disease: a statement for healthcare professionals from the nutrition committee of the AHA. American Heart Association Nutrition Committee. Circulation 2000, 102:2555-2559.
26. Food labeling, health claims, soy protein, and coronary heart disease. Food and Drug Administration [no authors listed]. Fed Reg 1999, 57:699-733.
27. Bhathena SJ, Velasquez MT: Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002, 76:1191-1201.
28. Teede HJ, Dalais FS, Kotsopoulos D, et al.: Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001, 86:3053-3060.
29. Tonstad S, Smerud K, Hoie L: A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 2002, 76:78-84.
30. Hermansen K, Sondergaard M, Hoie L, et al.: Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 2001, 24:228-233.
31. Cicero AF, Fiorito A, Panourgia MP, et al.: Effects of a new soy/beta-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects. J Am Diet Assoc 2002, 102:1807-1811.
32. Jenkins DJA, Kendall CWC, Jackson CC, et al.: Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 2002, 76:365-372.
33. Underbakke G: Medical nutrition therapy for cardiovascular disease - beyond the basics. On the Cutting Edge 2002, 23:19-22.
34. Jenkins DJ, Kendall CW, Faulkner D, et al.: A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 2002, 51:1596-1604.
35. Gaede P, Vedel P, Larsen N, et al.: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393.
36. Park YW, Zhu S, Palaniappan L, et al.: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003, 163:427-346.
37. Yang EJ, Chung HK, Kim WY, et al.: Carbohydrate intake is associated with diet quality and risk factors for cardiovascular disease in U.S. adults: NHANES III. J Am Coll Nutr 2002, 22:71-79.
38. Mensink RP, Katan MB: Effect dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992, 12:911-919.
39. Garg A: High-monounsaturated fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998, 67(suppl):577S-582S.
40. Louheranta AM, Sarkkinen ES, Vidgren HM, et al.: Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance. Am J Clin Nutr 2002, 76:331-337.
41. Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
42. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE: Fish oil and glycemic control in diabetes: a meta analysis. Diabetes Care 1998, 21:494-500.
43. Woodman RJ, Mori TA, Burke V, et al.: Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002, 76:1007-1015.
44. Tarpila S, Aro, A, Salminen I, et al.: The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone. Eur J Clin Nutr 2002, 56:157-165.
45. Lucas EA, Wild RD, Hammond LJ, et al.: Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002, 87:1527-1532.
46. de Lorgeril M, Salen P, Martin JL, et al.: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779-785.
47. Albert CM, Campos H, Stampfer MJ, et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346:1113-1118.
48. Lovejoy JC, Most MM, Lefevre M, et al.: Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 2002, 76:1000-1006.
49. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Washington, DC: National Institutes of Health, National Heart Lung and Blood Institute; 1998. http://www.nhlbi.nih.gov/guidelines/obesity/e_txtbk/index.htm. Accessed April 1, 2003.
50. Kris-Etherton PM, Etherton TD, Carlson J, Gardner C: Recent discoveries in inclusive food-based approaches and dietary patterns for reduction in risk for cardiovascular disease. Curr Opin Lipidol 2002, 13:397-407.